701 related articles for article (PubMed ID: 23902406)
1. Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism.
Hill TD; Cascio MG; Romano B; Duncan M; Pertwee RG; Williams CM; Whalley BJ; Hill AJ
Br J Pharmacol; 2013 Oct; 170(3):679-92. PubMed ID: 23902406
[TBL] [Abstract][Full Text] [Related]
2. Cannabidivarin is anticonvulsant in mouse and rat.
Hill AJ; Mercier MS; Hill TD; Glyn SE; Jones NA; Yamasaki Y; Futamura T; Duncan M; Stott CG; Stephens GJ; Williams CM; Whalley BJ
Br J Pharmacol; 2012 Dec; 167(8):1629-42. PubMed ID: 22970845
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of cannabinoids in the treatment of epilepsy.
Gaston TE; Friedman D
Epilepsy Behav; 2017 May; 70(Pt B):313-318. PubMed ID: 28087250
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant effect of cannabidiol in the pentylenetetrazole model: Pharmacological mechanisms, electroencephalographic profile, and brain cytokine levels.
Vilela LR; Lima IV; Kunsch ÉB; Pinto HPP; de Miranda AS; Vieira ÉLM; de Oliveira ACP; Moraes MFD; Teixeira AL; Moreira FA
Epilepsy Behav; 2017 Oct; 75():29-35. PubMed ID: 28821005
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats.
Rock EM; Sticht MA; Duncan M; Stott C; Parker LA
Br J Pharmacol; 2013 Oct; 170(3):671-8. PubMed ID: 23902479
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
Rosenberg EC; Patra PH; Whalley BJ
Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
[TBL] [Abstract][Full Text] [Related]
8. Cannabis sativa: Much more beyond Δ
Alves P; Amaral C; Teixeira N; Correia-da-Silva G
Pharmacol Res; 2020 Jul; 157():104822. PubMed ID: 32335286
[TBL] [Abstract][Full Text] [Related]
9. Preclinical safety and efficacy of cannabidivarin for early life seizures.
Huizenga MN; Sepulveda-Rodriguez A; Forcelli PA
Neuropharmacology; 2019 Apr; 148():189-198. PubMed ID: 30633929
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol.
Romano B; Borrelli F; Pagano E; Cascio MG; Pertwee RG; Izzo AA
Phytomedicine; 2014 Apr; 21(5):631-9. PubMed ID: 24373545
[TBL] [Abstract][Full Text] [Related]
11. Species-specific susceptibility to cannabis-induced convulsions.
Whalley BJ; Lin H; Bell L; Hill T; Patel A; Gray RA; Elizabeth Roberts C; Devinsky O; Bazelot M; Williams CM; Stephens GJ
Br J Pharmacol; 2019 May; 176(10):1506-1523. PubMed ID: 29457829
[TBL] [Abstract][Full Text] [Related]
12. Arachidonyl-2'-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Czuczwar P; Cioczek-Czuczwar A; Czuczwar SJ
Eur J Pharmacol; 2006 Oct; 547(1-3):65-74. PubMed ID: 16930590
[TBL] [Abstract][Full Text] [Related]
13. The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy.
Wallace MJ; Blair RE; Falenski KW; Martin BR; DeLorenzo RJ
J Pharmacol Exp Ther; 2003 Oct; 307(1):129-37. PubMed ID: 12954810
[TBL] [Abstract][Full Text] [Related]
14. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.
De Petrocellis L; Ligresti A; Moriello AS; Allarà M; Bisogno T; Petrosino S; Stott CG; Di Marzo V
Br J Pharmacol; 2011 Aug; 163(7):1479-94. PubMed ID: 21175579
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB
Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.
Jones NA; Hill AJ; Smith I; Bevan SA; Williams CM; Whalley BJ; Stephens GJ
J Pharmacol Exp Ther; 2010 Feb; 332(2):569-77. PubMed ID: 19906779
[TBL] [Abstract][Full Text] [Related]
17. Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se.
Hill AJ; Jones NA; Smith I; Hill CL; Williams CM; Stephens GJ; Whalley BJ
Neurosci Lett; 2014 Apr; 566():269-74. PubMed ID: 24642454
[TBL] [Abstract][Full Text] [Related]
18. Effect of ACEA--a selective cannabinoid CB1 receptor agonist on the protective action of different antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model.
Andres-Mach M; Zolkowska D; Barcicka-Klosowska B; Haratym-Maj A; Florek-Luszczki M; Luszczki JJ
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):301-9. PubMed ID: 22789660
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol anticonvulsant effect is mediated by the PI3Kγ pathway.
Lima IVA; Bellozi PMQ; Batista EM; Vilela LR; Brandão IL; Ribeiro FM; Moraes MFD; Moreira FA; de Oliveira ACP
Neuropharmacology; 2020 Oct; 176():108156. PubMed ID: 32574650
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects.
Wallace MJ; Wiley JL; Martin BR; DeLorenzo RJ
Eur J Pharmacol; 2001 Sep; 428(1):51-7. PubMed ID: 11779037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
